Panel‐based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory
Open Access
- 20 March 2014
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 86 (6), 510-520
- https://doi.org/10.1111/cge.12359
Abstract
Next-generation sequencing enables testing for multiple genes simultaneously (‘panel-based testing’) as opposed to sequential testing for one inherited condition at a time (‘syndrome-based testing’). This study presents results from patients who underwent hereditary colorectal cancer (CRC) panel-based testing (‘ColoNext™’). De-identified data from a clinical testing laboratory were used to calculate (1) frequencies for patient demographic, clinical, and family history variables and (2) rates of pathogenic mutations and variants of uncertain significance (VUS). The proportion of individuals with a pathogenic mutation who met national syndrome-based testing criteria was also determined. Of 586 patients, a pathogenic mutation was identified in 10.4%, while 20.1% had at least one VUS. After removing eight patients with CHEK2 mutations and 11 MUTYH heterozygotes, the percentage of patients with ‘actionable’ mutations that would clearly alter cancer screening recommendations per national guidelines decreased to 7.2%. Of 42 patients with an ‘actionable’ result, 30 (71%) clearly met established syndrome-based testing guidelines. This descriptive study is among the first to report on a large clinical series of patients undergoing panel-based testing for inherited CRC. Results are discussed in the context of benefits and concerns that have been raised about panel-based testing implementation.Keywords
This publication has 25 references indexed in Scilit:
- Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature reviewHereditary Cancer in Clinical Practice, 2013
- Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?Journal of Clinical Oncology, 2013
- Genetic testing and cancer risk management recommendations by physicians for at-risk relativesGenetics in Medicine, 2011
- Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future researchJournal of Medical Genetics, 2010
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingProceedings of the National Academy of Sciences, 2010
- Massively Parallel Sequencing: The Next Big Thing in Genetic MedicineAmerican Journal of Human Genetics, 2009
- EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndromeGenetics in Medicine, 2009
- Keeping Up With the Next Generation: Massively Parallel Sequencing in Clinical DiagnosticsThe Journal of Molecular Diagnostics, 2008
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Colorectal Cancer Risk in Monoallelic Carriers of MYH VariantsAmerican Journal of Human Genetics, 2006